Target intelligence / Profile preview

RNA, U2 small nuclear 54, pseudogene (RNU2-54P)

Target
RNU2-54P
Molecular classification
pseudogene, non-coding RNA, small nuclear pseudogene
01

Overview

RNU2-54P is a pseudogene for U2 small nuclear RNA, which means it is a non-functional genomic DNA sequence similar to the gene encoding U2 snRNA, a critical component of the spliceosome complex responsible for pre-mRNA splicing in eukaryotes[2][1]. Unlike functional U2 snRNA genes, pseudogenes like RNU2-54P are generally not transcribed into a functional product and do not participate in splicing or other biological processes. Functional U2 snRNA is required for spliceosome assembly and mRNA maturation, but there is no experimental or clinical evidence that RNU2-54P is a therapeutic target or that it has any direct role in disease or drug mechanism[2][1][3]. Key clarification: - The naming and classification explicitly describe it as a pseudogene, which by definition is a non-functional remnant of a gene[3]. There are many U2 snRNA pseudogene loci in the human genome; these are not therapeutic targets. - By convention in biomedical databases, pseudogenes such as RNU2-54P are not considered valid drug, receptor, enzyme, or pathway targets. - If inquiry concerns U2 small nuclear RNA itself (not a pseudogene), refer instead to the functional "U2 snRNA," which is a core component of the spliceosome and essential for mRNA processing[2][1].

Other names
RNU2-54PU2 snRNA pseudogene 54

Beyond the preview

Go deeper on RNA, U2 small nuclear 54, pseudogene (RNU2-54P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 54, pseudogene (RNU2-54P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call